Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Invasive Ductal Breast Carcinoma
Interventions: DRUG: Carboplatin|DRUG: Abraxane|DRUG: MPDL3280A|PROCEDURE: Surgery|DRUG: Anthra
Sponsor: Fondazione Michelangelo